# STOK (Stoke Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Stoke Therapeutics, Inc. reported $28.21M in revenue and a net loss of $243.2M for the trailing twelve months ended September 30, 2026 (up 5.9% year over year), with a -913.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/STOK
- Markdown: https://convexityos.com/fundamentals/STOK.md
- SEC CIK: 0001623526
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:24 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001623526&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $28.21M | +5.9% YoY |
| Operating Income | TTM | -$257.6M | -913.1% margin |
| Net Income | TTM | -$243.2M | -862.1% net margin |
| Diluted EPS | TTM | -$3.56 | Split-adjusted |
| Free Cash Flow | TTM | -$215.7M | -764.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $319.2M | Total debt: $1.92M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $184.4M | $36.55M | $8.78M | $12.40M | -- | -- | -- | -- |
| Research & Development | $137.9M | $89.13M | $82.23M | $77.84M | $54.17M | $32.20M | $23.76M | $8.37M |
| Selling, General & Admin | $67.09M | $48.79M | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $205.0M | $137.9M | $123.6M | $116.8M | $86.06M | $53.04M | $35.68M | $12.78M |
| **Operating Income** | -$20.59M | -$101.4M | -$114.8M | -$104.4M | -$86.06M | -$53.04M | -$35.68M | -$12.78M |
| **EBITDA** | -$18.82M | -$99.19M | -$112.3M | -$102.8M | -$85.09M | -$52.16M | -$35.23M | -$12.57M |
| Interest Income | $13.77M | $12.66M | $9.96M | -- | -- | $744K | $3.35M | $270K |
| Interest Expense | $9.0K | $26K | $49K | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$6.88M | -$88.98M | -$104.7M | -$101.1M | -$85.81M | -$52.24M | -$32.33M | -$12.52M |
| Basic EPS | -$0.12 | -$1.65 | -$2.38 | -$2.60 | -$2.34 | -$1.56 | -$1.80 | -$17.65 |
| **Diluted EPS** | -$0.12 | -$1.65 | -$2.38 | -$2.60 | -$2.34 | -$1.56 | -$1.80 | -$17.65 |
| Basic Shares Outstanding | 59.2M | 54.0M | 44.0M | 38.9M | 36.7M | 33.5M | 18.0M | 709.3K |
| Diluted Shares Outstanding | 59.2M | 54.0M | 44.0M | 38.9M | 36.7M | 33.5M | 18.0M | 709.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $11.26M | $9.32M | $6.23M | $1.40M | $10.63M | $13.82M | $158.6M | $22.61M |
| Research & Development | $59.83M | $49.50M | $39.67M | $41.70M | $37.70M | $25.86M | $32.68M | $23.42M |
| Selling, General & Admin | $28.74M | $25.25M | $19.97M | $21.15M | $16.03M | $15.26M | $14.65M | -- |
| Total Operating Expenses | $88.57M | $74.75M | $59.65M | $62.84M | $53.72M | $41.12M | $47.33M | $36.27M |
| **Operating Income** | -$77.31M | -$65.43M | -$53.42M | -$61.44M | -$43.09M | -$27.30M | $111.2M | -$13.65M |
| **EBITDA** | -$76.86M | -$64.97M | -$52.98M | -$61.03M | -$42.65M | -$26.85M | $111.7M | -$13.13M |
| Interest Income | $3.69M | $3.52M | $3.42M | $3.62M | $3.47M | $3.79M | $2.89M | $2.97M |
| Interest Expense | $20K | $17K | $23K | $3.0K | $3.0K | $3.0K | $1.0K | -$1.0K |
| Income Before Tax | -$73.64M | -$61.62M | -$50.00M | -- | -$39.62M | -$23.48M | $114.2M | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$1.28M | $0 | $1.28M | -- |
| **Net Income** | -$73.64M | -$61.62M | -$50.00M | -$57.93M | -$38.35M | -$23.48M | $112.9M | -$10.48M |
| Basic EPS | -$1.08 | -$0.93 | -$0.79 | -- | -$0.65 | -$0.40 | $1.95 | -- |
| **Diluted EPS** | -$1.08 | -$0.93 | -$0.79 | -- | -$0.65 | -$0.40 | $1.90 | -- |
| Basic Shares Outstanding | 68.4M | 66.0M | 63.1M | -- | 58.6M | 58.4M | 57.9M | -- |
| Diluted Shares Outstanding | 68.4M | 66.0M | 63.1M | -- | 58.6M | 58.4M | 59.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $84.22M | $128.0M | $191.4M | $113.6M | $144.9M | $287.3M | $222.5M | $105.4M |
| Short-Term Investments | $200.4M | $88.92M | $9.95M | $116.0M | $74.92M | $0 | -- | -- |
| **Cash & Short-Term Investments** | $284.7M | $216.9M | $201.4M | $229.6M | $219.8M | $287.3M | $222.5M | $105.4M |
| Accounts Receivable, Net | $5.94M | $1.67M | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $4.39M | $2.30M | $2.56M | $2.96M | $2.22M | -- | -- | -- |
| **Total Current Assets** | $305.7M | $232.8M | $215.3M | $244.1M | $229.2M | $293.9M | $226.0M | $106.1M |
| Property, Plant & Equipment, Net | $3.15M | $3.91M | $5.82M | $6.67M | $4.14M | $2.67M | $2.51M | $1.19M |
| Long-Term Investments | $106.3M | $29.82M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $112.7M | $38.80M | $13.00M | $12.00M | $9.65M | $4.00M | $2.72M | $1.40M |
| **Total Assets** | $418.4M | $271.6M | $228.3M | $256.1M | $238.9M | $297.9M | $228.8M | $107.5M |
| Accounts Payable | $4.94M | $2.50M | $1.70M | $766K | $2.38M | $1.50M | $751K | $1.07M |
| Deferred Revenue (Current) | $11.90M | $18.99M | $15.31M | $14.88M | -- | -- | -- | -- |
| Other Current Liabilities | $1.06M | $753K | $857K | $509K | $540K | $459K | $54K | -- |
| **Total Current Liabilities** | $57.88M | $40.06M | $30.82M | $31.39M | $17.14M | $11.43M | $4.10M | $2.47M |
| Deferred Revenue (Non-Current) | $6.96M | -- | $33.07M | $36.86M | -- | -- | -- | -- |
| Other Non-Current Liabilities | $1.14M | $2.48M | $4.88M | $2.97M | $3.95M | -- | -- | -- |
| **Total Non-Current Liabilities** | $8.10M | $2.48M | $37.96M | $39.82M | $3.95M | $422K | $221K | $4.0K |
| **Total Liabilities** | $65.98M | $42.53M | $68.78M | $71.22M | $21.09M | $11.85M | $4.32M | $2.47M |
| **Total Debt (incl. Leases)** | $4.15M | $4.77M | $6.83M | $5.08M | $6.97M | $1.15M | -- | -- |
| Common Stock | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | -- |
| Retained Earnings | -$497.7M | -$490.8M | -$401.8M | -$297.1M | -$196.1M | -$110.3M | -$58.03M | -$25.71M |
| Accumulated Other Comp. Income | $543K | -$151K | -$24K | -$1.18M | -$168K | -- | -- | -- |
| **Total Stockholders' Equity** | $352.5M | $229.0M | $159.6M | $184.8M | $217.8M | $286.1M | $224.4M | $105.1M |
| Total Equity | $352.5M | $229.0M | $159.6M | $184.8M | $217.8M | $286.1M | $224.4M | $105.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $107.3M | $110.0M | $155.7M | $84.22M | $83.39M | $101.5M | $274.8M | $128.0M |
| Short-Term Investments | $211.9M | $182.8M | $187.9M | $200.4M | $164.9M | $146.2M | $82.51M | $88.92M |
| **Cash & Short-Term Investments** | $319.2M | $292.8M | $343.5M | $284.7M | $248.3M | $247.7M | $357.3M | $216.9M |
| Accounts Receivable, Net | $8.54M | $7.18M | $4.45M | $5.94M | $9.25M | -- | -- | $1.67M |
| Other Current Assets | $7.56M | $6.31M | $6.88M | $4.39M | $5.54M | $6.87M | $5.04M | $2.30M |
| **Total Current Assets** | $354.4M | $322.5M | $366.7M | $305.7M | $272.4M | $270.0M | $375.7M | $232.8M |
| Property, Plant & Equipment, Net | $8.21M | $4.83M | $3.40M | $3.15M | $3.08M | $3.34M | $3.61M | $3.91M |
| Long-Term Investments | $39.60M | $61.50M | $67.48M | $106.3M | $80.31M | $107.3M | $22.99M | $29.82M |
| **Total Non-Current Assets** | $52.27M | $71.43M | $76.60M | $112.7M | $87.83M | $114.5M | $31.15M | $38.80M |
| **Total Assets** | $406.7M | $394.0M | $443.3M | $418.4M | $360.3M | $384.5M | $406.9M | $271.6M |
| Accounts Payable | $4.03M | $4.79M | $6.84M | $4.94M | $5.87M | $4.31M | $2.19M | $2.50M |
| Deferred Revenue (Current) | $6.36M | $8.52M | $10.07M | $11.90M | $5.76M | $8.75M | $18.16M | $18.99M |
| Other Current Liabilities | $1.75M | $1.62M | $1.50M | $1.06M | $795K | $1.75M | $2.07M | $753K |
| **Total Current Liabilities** | $48.98M | $41.93M | $40.81M | $57.88M | $41.73M | $38.68M | $44.69M | $40.06M |
| Deferred Revenue (Non-Current) | $4.45M | $5.65M | $6.60M | $6.96M | $8.56M | $9.63M | $10.26M | -- |
| Other Non-Current Liabilities | $681K | $837K | $991K | $1.14M | $1.87M | $1.25M | $1.87M | $2.48M |
| **Total Non-Current Liabilities** | $5.13M | $6.49M | $7.59M | $8.10M | $10.43M | $10.89M | $12.13M | $2.48M |
| **Total Liabilities** | $54.10M | $48.42M | $48.40M | $65.98M | $52.16M | $49.56M | $56.81M | $42.53M |
| **Total Debt (incl. Leases)** | $1.92M | $2.68M | $3.42M | $4.15M | $4.78M | $5.28M | $5.95M | $4.77M |
| Common Stock | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$683.0M | -$609.3M | -$547.7M | -$497.7M | -$439.8M | -$401.4M | -$378.0M | -$490.8M |
| Accumulated Other Comp. Income | -$1.05M | -$542K | -$115K | $543K | $446K | $96K | -$104K | -$151K |
| **Total Stockholders' Equity** | $352.6M | $345.5M | $394.9M | $352.5M | $308.1M | $334.9M | $350.1M | $229.0M |
| Total Equity | $352.6M | $345.5M | $394.9M | $352.5M | $308.1M | $334.9M | $350.1M | $229.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.88M | -$88.98M | -$104.7M | -$101.1M | -$85.81M | -$52.24M | -$32.33M | -$12.52M |
| Depreciation & Amortization | $1.77M | $2.18M | $2.47M | $1.55M | $974K | $888K | $450K | $214K |
| Stock-Based Compensation | $32.24M | $27.47M | $25.26M | $22.85M | $16.45M | $5.77M | $1.92M | $240K |
| Change in Receivables | -$4.27M | -$50K | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | $45.59M | -$86.85M | -$81.07M | -$31.87M | -$66.91M | -$42.22M | -$31.05M | -$10.96M |
| Capital Expenditure | -$670K | -$203K | -$1.62M | -$3.96M | -$1.20M | -$1.05M | -$1.64M | -$935K |
| **Free Cash Flow** | $44.91M | -$87.05M | -$82.68M | -$35.83M | -$68.11M | -$43.27M | -$32.69M | -$11.90M |
| Purchases of Investments | -$322.7M | -$167.3M | $0 | -$201.3M | -$87.23M | -- | -- | -- |
| **Investing Cash Flow** | -$186.8M | -$107.5M | $105.9M | -$45.88M | -$76.43M | -$1.05M | -$1.63M | -$925K |
| **Financing Cash Flow** | $97.39M | $131.1M | $53.01M | $46.41M | $1.28M | $108.1M | $149.8M | $115.6M |
| **Net Change in Cash** | -$43.84M | -$63.23M | $77.89M | -$31.34M | -$142.0M | $64.84M | $117.1M | $103.8M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$73.64M | -$61.62M | -$50.00M | -$57.93M | -$38.35M | -$23.48M | $112.9M | -$10.48M |
| Depreciation & Amortization | $455K | $458K | $439K | $405K | $442K | $446K | $477K | $526K |
| Stock-Based Compensation | $11.03M | $10.80M | $8.75M | $9.85M | $8.04M | $7.60M | $6.75M | $7.14M |
| Change in Receivables | -$1.36M | -$2.73M | $1.49M | $3.31M | -$11.33M | $5.08M | -$1.32M | -- |
| **Operating Cash Flow** | -$62.69M | -$56.59M | -$60.58M | -$30.45M | -$30.37M | -$25.42M | $131.8M | -$23.19M |
| Capital Expenditure | -$2.85M | -$1.98M | -$353K | -$232K | -$132K | -$154K | -$152K | -$42K |
| **Free Cash Flow** | -$65.54M | -$58.56M | -$60.94M | -$30.69M | -$30.50M | -$25.58M | $131.7M | -$23.23M |
| Purchases of Investments | -$58.01M | -$36.11M | -$9.85M | -$98.23M | -$23.93M | -$181.6M | -$19.02M | -- |
| **Investing Cash Flow** | -$10.21M | $9.02M | $50.69M | -$61.06M | $9.09M | -$148.5M | $13.63M | $819K |
| **Financing Cash Flow** | $70.16M | $1.91M | $84.33M | $92.34M | $3.12M | $554K | $1.37M | $568K |
| **Net Change in Cash** | -$2.73M | -$45.66M | $74.44M | $826K | -$18.15M | -$173.3M | $146.8M | -$21.81M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -11.2% | -277.3% | -1307.2% | -841.2% | -- | -- | -- | -- |
| **Net Profit Margin** | -3.7% | -243.4% | -1192.5% | -814.7% | -- | -- | -- | -- |
| Return on Equity (ROE) | -2.0% | -38.9% | -65.6% | -54.7% | -39.4% | -18.3% | -14.4% | -11.9% |
| Return on Assets (ROA) | -1.6% | -32.8% | -45.9% | -39.5% | -35.9% | -17.5% | -14.1% | -11.6% |
| Current Ratio | 5.28x | 5.81x | 6.99x | 7.77x | 13.37x | 25.73x | 55.12x | 43.03x |
| Quick Ratio | 5.02x | 5.46x | 6.53x | 7.31x | 12.83x | 25.15x | 54.25x | 42.72x |
| Debt to Equity | 0.01x | 0.02x | 0.04x | 0.03x | 0.03x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | +404.5% | +316.3% | -29.2% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -913.1% | -809.7% | -577.5% | -11.2% | 13.2% | 20.2% | 20.0% | -277.3% |
| **Net Profit Margin** | -862.1% | -753.6% | -529.2% | -3.7% | 19.7% | 26.3% | 26.3% | -243.4% |
| Return on Equity (ROE) | -69.0% | -60.2% | -43.0% | -2.0% | 13.2% | 15.7% | 14.4% | -38.9% |
| Return on Assets (ROA) | -59.8% | -52.8% | -38.3% | -1.6% | 11.3% | 13.6% | 12.4% | -32.8% |
| Current Ratio | 7.24x | 7.69x | 8.99x | 5.28x | 6.53x | 6.98x | 8.41x | 5.81x |
| Quick Ratio | 6.69x | 7.15x | 8.53x | 5.02x | 6.17x | 6.40x | 8.00x | 5.46x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x |
| **Revenue Growth (YoY)** | +5.9% | -32.5% | -96.1% | -93.8% | +117.2% | +186.0% | +3661.1% | +707.1% |
| Operating Income Growth (YoY) | -- | -- | -148.0% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -144.3% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -140.5% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -146.0% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -146.3% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
